BNTX

Biontech Stock Analysis

AI Rating

Neutral
  • Quality6/10
  • Growth↓ 4/10
  • Momentum↑ 5/10
Biontech sales and earnings growth
BNTX Growth
Neutral
  • Revenue Y/Y↓ 3.70%
  • EPS Y/Y↓ -21.54%
  • FCF Y/Y↓ -204.88%
Biontech gross and profit margin trends
BNTX Profitability
Neutral
  • Gross margin ↑ 82.50%
  • EPS margin↓ -18.10%
  • ROIC↓ -5.00%
Biontech net debt vs free cash flow
BNTX Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -5.6

Biontech stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗